StockNews.com Downgrades Cimpress (NASDAQ:CMPR) to Buy

StockNews.com lowered shares of Cimpress (NASDAQ:CMPR – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Monday. Other research analysts have also recently issued reports about the company. Barrington Research increased their price target on Cimpress from $113.00 to $119.00 and gave the company an “outperform” […]

Leave a Reply

Your email address will not be published.

Previous post Nurix Therapeutics (NASDAQ:NRIX) Given Overweight Rating at Stephens
Next post Cognizant Technology Solutions (NASDAQ:CTSH) Upgraded at StockNews.com